Overexpression of FOXM1 Is Associated With Poor Prognosis and Clinicopathologic Stage of Pancreatic Ductal Adenocarcinoma

Pancreas, 04/30/2012

The finding indicates that forkhead box M1 (FoxM1) could be used as prognostic molecular marker and therapeutic target for pancreatic ductal adenocarcinoma (PDA).

Print Article Summary Cat 2 CME Report